Topotecan Hydrochloride for Injection 1 mg (Topotecan (Topotecan Hydrochloride) SOLUTION) 1 MG

Topotecan Hydrochloride for Injection 1 mg is a cancer treatment medication. This intravenous solution is used to manage certain types of cancer. Learn more about its uses and effects.

Strength

1 MG

Pack Size

4ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Topotecan Hydrochloride for Injection 1 mg is primarily used in cancer treatment. It is often prescribed for advanced ovarian cancer and small cell lung cancer. The medication works by slowing the growth of cancer cells. Patients should consult their healthcare provider to understand what Topotecan is used for in their specific case.

Side Effects

Common effects of Topotecan Hydrochloride for Injection 1 mg may include nausea, vomiting, and fatigue. Some patients may experience low blood cell counts, which can increase the risk of infections. It is important to discuss any unusual symptoms with a healthcare professional.

Precautions & Warnings

Topotecan Hydrochloride for Injection 1 mg should be handled with care. It is important to follow the storage and administration instructions provided by the healthcare provider. Pregnant women and individuals with certain medical conditions should use this medication with caution.

Avoid Interactions

Topotecan Hydrochloride for Injection 1 mg may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Topotecan Hydrochloride for Injection 1 mg is used in the treatment of certain types of cancer, such as advanced ovarian cancer and small cell lung cancer.

Topotecan Hydrochloride for Injection 1 mg is administered intravenously by a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, and low blood cell counts.

Pregnant women should use Topotecan Hydrochloride for Injection 1 mg with caution and consult their healthcare provider.

Topotecan Hydrochloride for Injection 1 mg should be stored according to the instructions provided by the healthcare provider or pharmacist.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.